Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Feb 10, 2026

Carotid Artery Infusions for Pharmacokinetic and Pharmacodynamic Analysis of Taxanes in Mice
08:41

Carotid Artery Infusions for Pharmacokinetic and Pharmacodynamic Analysis of Taxanes in Mice

Published on: October 27, 2014

24.0K

Taxane pharmacogenetics.

Sharon Marsh1

  • 1Washington University School of Medicine, Division of Oncology, 660 South Euclid Ave - Campus Box 8069, St Louis, MO 63110, USA. smarsh@im.wustl.edu.

Personalized Medicine
|May 23, 2018
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Integrating genomic-based clinical decision support into electronic health records.

Personalized medicine·2018
Same author

Fast and frugal trees: translating population-based pharmacogenomics to medication prioritization.

Personalized medicine·2018
Same author

eHealth: past and future perspectives.

Personalized medicine·2018
Same author

Validation of microRNA pathway polymorphisms in esophageal adenocarcinoma survival.

Cancer medicine·2017
Same author

A Bridging Opportunities Work-frame to develop mobile applications for clinical decision making.

Future science OA·2016
Same author

The Pathogenesis of Nonalcoholic Fatty Liver Disease: Interplay between Diet, Gut Microbiota, and Genetic Background.

Gastroenterology research and practice·2016
Same journal

Digital biomarkers in chronic disease management: a systematic review of personalization and ethical challenges.

Personalized medicine·2026
Same journal

Toward a harmonized assessment of MRD by NGS: blinded pilot study of NGS assays by MPAACT consortium.

Personalized medicine·2026
Same journal

Expression levels of microRNA-550a-5p in patients with spinal metastases from non-small cell lung cancer.

Personalized medicine·2026
Same journal

Epigenetic and genetic insights for tailored therapeutic strategies in multiple sclerosis.

Personalized medicine·2026
Same journal

Deciphering the multi-organ anti-fibrotic mechanisms of pirfenidone and nintedanib via network pharmacology.

Personalized medicine·2026
Same journal

Association between microRNA 155 gene polymorphism and sporadic Parkinson's disease.

Personalized medicine·2026
See all related articles

Taxanes like paclitaxel and docetaxel show variable patient responses and toxicity. Epigenetic factors may explain these differences, guiding personalized cancer therapy.

Area of Science:

  • Oncology
  • Pharmacogenomics

Background:

  • Taxanes (paclitaxel, docetaxel) are chemotherapy drugs that stabilize microtubules, inhibiting cancer cell division.
  • Significant interindividual variability exists in patient response and toxicity to these taxanes.
  • Genetic variations in taxane metabolism and transport genes are known, but useful predictive markers are limited.

Purpose of the Study:

  • To explore the role of epigenetic regulation in explaining the variability of taxane response and toxicity.
  • To identify potential epigenetic markers for individualized taxane therapy.

Main Methods:

  • Review of existing literature on taxane pharmacokinetics, pharmacodynamics, and pharmacogenetics.
  • Analysis of studies investigating epigenetic modifications (e.g., DNA methylation, histone modification) in taxane pathway genes.
Keywords:
cancerdocetaxelepigeneticmicrotubulepaclitaxelpharmacogeneticspolymorphismtaxane

More Related Videos

Live Imaging to Study Microtubule Dynamic Instability in Taxane-resistant Breast Cancers
06:02

Live Imaging to Study Microtubule Dynamic Instability in Taxane-resistant Breast Cancers

Published on: February 20, 2017

8.0K
Evaluation of Colorectal Cancer Risk and Prevalence by Stool DNA Integrity Detection
07:35

Evaluation of Colorectal Cancer Risk and Prevalence by Stool DNA Integrity Detection

Published on: June 8, 2020

7.5K

Related Experiment Videos

Last Updated: Feb 10, 2026

Carotid Artery Infusions for Pharmacokinetic and Pharmacodynamic Analysis of Taxanes in Mice
08:41

Carotid Artery Infusions for Pharmacokinetic and Pharmacodynamic Analysis of Taxanes in Mice

Published on: October 27, 2014

24.0K
Live Imaging to Study Microtubule Dynamic Instability in Taxane-resistant Breast Cancers
06:02

Live Imaging to Study Microtubule Dynamic Instability in Taxane-resistant Breast Cancers

Published on: February 20, 2017

8.0K
Evaluation of Colorectal Cancer Risk and Prevalence by Stool DNA Integrity Detection
07:35

Evaluation of Colorectal Cancer Risk and Prevalence by Stool DNA Integrity Detection

Published on: June 8, 2020

7.5K
  • Correlation of epigenetic alterations with observed patient response and toxicity data.

    • Main Results:

    • Genetic variability alone does not fully account for interpatient differences in taxane efficacy and side effects.
    • Emerging evidence suggests epigenetic mechanisms significantly influence the expression and function of genes involved in taxane action.
    • Specific epigenetic patterns may be associated with heightened taxane toxicity or reduced treatment response.

    Conclusions:

    • Epigenetic regulation of taxane pathway genes is a critical factor contributing to variable patient outcomes.
    • Targeting epigenetic modifications could offer novel strategies for personalizing taxane chemotherapy.
    • Further research into epigenetic markers is warranted for improved patient selection and treatment optimization.